Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
- Type
- Expression of concern
- Notice date
- 10/14/2020 0:00
- Journal
- PLoS One
- Publisher
- PLoS
- Notice DOI
- 10.1371/journal.pone.0240965
- Original paper DOI
- 10.1371/journal.pone.0239799